Cryopreservation is the only established method to provide long-term storage and fast availability of cellular product for therapeutic applications. The overwhelming majority of cryopreservation media contain toxic concentrations of dimethyl sulfoxide (DMSO) limiting the possibility for the direct administration of cryopreserved cells to the patients. Here, we propose a novel approach for nontoxic xeno-free cryopreservation of human multipotent mesenchymal stromal cells (MSCs) aimed at ensuring high viability, ready-to-use availability, and localized delivery of the cell-based graft into damaged tissues. For MSC cryopreservation, we applied sucrose pretreatment procedure and xeno-free cryoprotective medium containing human platelet-poor blood plasma (PPP), sucrose, and nontoxic concentration of DMSO. Using the combination of PPP, 0.2 M sucrose, and 1% DMSO, the recovery rate of cryopreserved MSCs reached 73% of the values obtained for noncryopreserved cells. Moreover, the presence of PPP in the cryoprotective medium provided the possibility to create a ready-to-use 3D hydrogel for the localized delivery and additional support of MSCs in vivo. In a proof-of-concept study, we assessed the regenerative capacity of cryopreserved MSCs in a full-thickness wound model in mice. The positive impact of MSCs within 3D gel on wound healing rates was confirmed by morphometric and histological examinations. Our results demonstrate the possibility to apply cryopreserved cells immediately after thawing using a cryoprotective medium as the vehicle solution.

Department of Biochemistry Institute for Problems of Cryobiology and Cryomedicine National Academy of Sciences of Ukraine Pereyaslavska 23 61015 Kharkiv Ukraine

Department of Biomaterials and Biophysical Methods Institute of Experimental Medicine AS CR v v i Videnska 1083 14220 Prague Czech Republic

State Institute of Genetic and Regenerative Medicine National Academy of Medical Sciences of Ukraine Kiev 04114 Ukraine

Zobrazit více v PubMed

Wu P., Zhang B., Shi H., Qian H., Xu W. MSC-exosome: a novel cell-free therapy for cutaneous regeneration. Cytotherapy. 2018;20(3):291–301. doi: 10.1016/j.jcyt.2017.11.002. PubMed DOI

Parekkadan B., Milwid J. M. Mesenchymal stem cells as therapeutics. Annual Review of Biomedical Engineering. 2010;12(1):87–117. doi: 10.1146/annurev-bioeng-070909-105309. PubMed DOI PMC

Lunyak V. V., Amaro-Ortiz A., Gaur M. Mesenchymal stem cells secretory responses: senescence messaging secretome and immunomodulation perspective. Frontiers in Genetics. 2017;8:p. 220. doi: 10.3389/fgene.2017.00220. PubMed DOI PMC

Petrenko Y., Sykova E., Kubinova S. The therapeutic potential of three-dimensional multipotent mesenchymal stromal cell spheroids. Stem Cell Research & Therapy. 2017;8(1):p. 94. doi: 10.1186/s13287-017-0558-6. PubMed DOI PMC

Marquez-Curtis L. A., Janowska-Wieczorek A., McGann L. E., Elliott J. A. W. Mesenchymal stromal cells derived from various tissues: biological, clinical and cryopreservation aspects. Cryobiology. 2015;71(2):181–197. doi: 10.1016/j.cryobiol.2015.07.003. PubMed DOI

Ozturk S., Karagoz H. Experimental stem cell therapies on burn wound: do source, dose, timing and method matter? Burns. 2015;41(6):1133–1139. doi: 10.1016/j.burns.2015.01.005. PubMed DOI

Rodgers K., Jadhav S. S. The application of mesenchymal stem cells to treat thermal and radiation burns. Advanced Drug Delivery Reviews. 2018;123:75–81. doi: 10.1016/j.addr.2017.10.003. PubMed DOI

Jeevanantham V., Butler M., Saad A., Abdel-Latif A., Zuba-Surma E. K., Dawn B. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation. 2012;126(5):551–568. doi: 10.1161/CIRCULATIONAHA.111.086074. PubMed DOI PMC

Bang O. Y. Clinical trials of adult stem cell therapy in patients with ischemic stroke. Journal of Clinical Neurology. 2016;12(1):14–20. doi: 10.3988/jcn.2016.12.1.14. PubMed DOI PMC

Thirumala S., Goebel W. S., Woods E. J. Manufacturing and banking of mesenchymal stem cells. Expert Opinion on Biological Therapy. 2013;13(5):673–691. doi: 10.1517/14712598.2013.763925. PubMed DOI

Hunt C. J. Cryopreservation of human stem cells for clinical application: a review. Transfusion Medicine and Hemotherapy. 2011;38(2):107–123. doi: 10.1159/000326623. PubMed DOI PMC

Notman R., Noro M., O'Malley B., Anwar J. Molecular basis for dimethylsulfoxide (DMSO) action on lipid membranes. Journal of the American Chemical Society. 2006;128(43):13982–13983. doi: 10.1021/ja063363t. PubMed DOI

Windrum P., Morris T. C. M., Drake M. B., Niederwieser D., Ruutu T., on behalf of the EBMT Chronic Leukaemia Working Party Complications Subcommittee Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Bone Marrow Transplantation. 2005;36(7):601–603. doi: 10.1038/sj.bmt.1705100. PubMed DOI

Cox M. A., Kastrup J., Hrubisko M. Historical perspectives and the future of adverse reactions associated with haemopoietic stem cells cryopreserved with dimethyl sulfoxide. Cell and Tissue Banking. 2012;13(2):203–215. doi: 10.1007/s10561-011-9248-2. PubMed DOI

Ray S. S., Pramanik K., Sarangi S. K., Jain N. Serum-free non-toxic freezing solution for cryopreservation of human adipose tissue-derived mesenchymal stem cells. Biotechnology Letters. 2016;38(8):1397–1404. doi: 10.1007/s10529-016-2111-6. PubMed DOI

Shivakumar S. B., Bharti D., Jang S. J., et al. Cryopreservation of human Wharton’s jelly-derived mesenchymal stem cells following controlled rate freezing protocol using different cryoprotectants; a comparative study. International Journal of Stem Cells. 2015;8(2):155–169. doi: 10.15283/ijsc.2015.8.2.155. PubMed DOI PMC

Miyagi-Shiohira C., Kobayashi N., Saitoh I., et al. Evaluation of serum-free, xeno-free cryopreservation solutions for human adipose-derived mesenchymal stem cells. Cell Medicine. 2017;9(1-2):15–20. doi: 10.3727/215517916X693122. PubMed DOI PMC

Al-Saqi S. H., Saliem M., Quezada H. C., et al. Defined serum- and xeno-free cryopreservation of mesenchymal stem cells. Cell and Tissue Banking. 2015;16(2):181–193. doi: 10.1007/s10561-014-9463-8. PubMed DOI

Matsumura K., Hayashi F., Nagashima T., Hyon S. H. Long-term cryopreservation of human mesenchymal stem cells using carboxylated poly-l-lysine without the addition of proteins or dimethyl sulfoxide. Journal of Biomaterials Science Polymer Edition. 2013;24(12):1484–1497. doi: 10.1080/09205063.2013.771318. PubMed DOI

Naaldijk Y., Staude M., Fedorova V., Stolzing A. Effect of different freezing rates during cryopreservation of rat mesenchymal stem cells using combinations of hydroxyethyl starch and dimethylsulfoxide. BMC Biotechnology. 2012;12(1):p. 49. doi: 10.1186/1472-6750-12-49. PubMed DOI PMC

Naaldijk Y., Johnson A. A., Friedrich-Stockigt A., Stolzing A. Cryopreservation of dermal fibroblasts and keratinocytes in hydroxyethyl starch-based cryoprotectants. BMC Biotechnology. 2016;16(1):p. 85. doi: 10.1186/s12896-016-0315-4. PubMed DOI PMC

Yudintseva N. M., Pleskach N. M., Smagina L. V., Blinova M. I., Samusenko I. A., Pinaev G. P. Reconstruction of connective tissue from fibrin-based dermal equivalent transplanted to animals with experimental wounds. Cell and Tissue Biology. 2010;4(5):476–480. doi: 10.1134/S1990519X10050111. PubMed DOI

Bensaid W., Triffitt J. T., Blanchat C., Oudina K., Sedel L., Petite H. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials. 2003;24(14):2497–2502. doi: 10.1016/S0142-9612(02)00618-X. PubMed DOI

Murphy M. B., Blashki D., Buchanan R. M., et al. Adult and umbilical cord blood-derived platelet-rich plasma for mesenchymal stem cell proliferation, chemotaxis, and cryo-preservation. Biomaterials. 2012;33(21):5308–5316. doi: 10.1016/j.biomaterials.2012.04.007. PubMed DOI

Smagur A., Mitrus I., Ciomber A., et al. Comparison of the cryoprotective solutions based on human albumin vs. autologous plasma: its effect on cell recovery, clonogenic potential of peripheral blood hematopoietic progenitor cells and engraftment after autologous transplantation. Vox Sanguinis. 2015;108(4):417–424. doi: 10.1111/vox.12238. PubMed DOI

Petrenko Y. A., Rogulska O. Y., Mutsenko V. V., Petrenko A. Y. A sugar pretreatment as a new approach to the Me2So- and xeno-free cryopreservation of human mesenchymal stromal cells. CryoLetters. 2014;35(3):239–246. PubMed

Rogulska O., Petrenko Y., Petrenko A. DMSO-free cryopreservation of adipose-derived mesenchymal stromal cells: expansion medium affects post-thaw survival. Cytotechnology. 2017;69(2):265–276. doi: 10.1007/s10616-016-0055-2. PubMed DOI PMC

Zuk P. A., Zhu M., Ashjian P., et al. Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell. 2002;13(12):4279–4295. doi: 10.1091/mbc.e02-02-0105. PubMed DOI PMC

Obata S., Akeda K., Imanishi T., et al. Effect of autologous platelet-rich plasma-releasate on intervertebral disc degeneration in the rabbit anular puncture model: a preclinical study. Arthritis Research & Therapy. 2012;14(6):p. R241. doi: 10.1186/ar4084. PubMed DOI PMC

Dhurat R., Sukesh M. Principles and methods of preparation of platelet-rich plasma: a review and author’s perspective. Journal of Cutaneous and Aesthetic Surgery. 2014;7(4):189–197. doi: 10.4103/0974-2077.150734. PubMed DOI PMC

Dankberg F., Persidsky M. D. A test of granulocyte membrane integrity and phagocytic function. Cryobiology. 1976;13(4):430–432. doi: 10.1016/0011-2240(76)90098-5. PubMed DOI

Dunn L., Prosser H. C. G., Tan J. T. M., Vanags L. Z., Ng M. K. C., Bursill C. A. Murine model of wound healing. Journal of Visualized Experiments. 2013;(75, article e50265) doi: 10.3791/50265. PubMed DOI PMC

Rodrigues J. P., Paraguassu-Braga F. H., Carvalho L., Abdelhay E., Bouzas L. F., Porto L. C. Evaluation of trehalose and sucrose as cryoprotectants for hematopoietic stem cells of umbilical cord blood. Cryobiology. 2008;56(2):144–151. doi: 10.1016/j.cryobiol.2008.01.003. PubMed DOI

Petrenko Y. A., Jones D. R. E., Petrenko A. Y. Cryopreservation of human fetal liver hematopoietic stem/progenitor cells using sucrose as an additive to the cryoprotective medium. Cryobiology. 2008;57(3):195–200. doi: 10.1016/j.cryobiol.2008.08.003. PubMed DOI

Roy S., Arora S., Kumari P., Ta M. A simple and serum-free protocol for cryopreservation of human umbilical cord as source of Wharton’s jelly mesenchymal stem cells. Cryobiology. 2014;68(3):467–472. doi: 10.1016/j.cryobiol.2014.03.010. PubMed DOI

Gurruchaga H., Saenz Del Burgo L., Garate A., et al. Cryopreservation of human mesenchymal stem cells in an allogeneic bioscaffold based on platelet rich plasma and synovial fluid. Scientific Reports. 2017;7(1):p. 15733. doi: 10.1038/s41598-017-16134-6. PubMed DOI PMC

Houdek M. T., Wyles C. C., Stalboerger P. G., Terzic A., Behfar A., Moran S. L. Collagen and fractionated platelet-rich plasma scaffold for dermal regeneration. Plastic and Reconstructive Surgery. 2016;137(5):1498–1506. doi: 10.1097/PRS.0000000000002094. PubMed DOI

Borena B. M., Martens A., Broeckx S. Y., et al. Regenerative skin wound healing in mammals: state-of-the-art on growth factor and stem cell based treatments. Cellular Physiology and Biochemistry. 2015;36(1):1–23. doi: 10.1159/000374049. PubMed DOI

Sanchez M., Anitua E., Orive G., Mujika I., Andia I. Platelet-rich therapies in the treatment of orthopaedic sport injuries. Sports Medicine. 2009;39(5):345–354. doi: 10.2165/00007256-200939050-00002. PubMed DOI

Blanton M. W., Hadad I., Johnstone B. H., et al. Adipose stromal cells and platelet-rich plasma therapies synergistically increase revascularization during wound healing. Plastic and Reconstructive Surgery. 2009;123:56S–64S. doi: 10.1097/PRS.0b013e318191be2d. PubMed DOI

Bao P., Kodra A., Tomic-Canic M., Golinko M. S., Ehrlich H. P., Brem H. The role of vascular endothelial growth factor in wound healing. The Journal of Surgical Research. 2009;153(2):347–358. doi: 10.1016/j.jss.2008.04.023. PubMed DOI PMC

Akita S., Akino K., Hirano A. Basic fibroblast growth factor in scarless wound healing. Advances in Wound Care. 2013;2(2):44–49. doi: 10.1089/wound.2011.0324. PubMed DOI PMC

Lin C. S., Lin G., Lue T. F. Allogeneic and xenogeneic transplantation of adipose-derived stem cells in immunocompetent recipients without immunosuppressants. Stem Cells and Development. 2012;21(15):2770–2778. doi: 10.1089/scd.2012.0176. PubMed DOI PMC

Autologous Mesenchymal Stromal Cells Immobilized in Plasma-Based Hydrogel for the Repair of Articular Cartilage Defects in a Large Animal Model

Mesenchymal stem cells of Oravka chicken breed: promising path to biodiversity conservation

Hypothermic Storage of 3D Cultured Multipotent Mesenchymal Stromal Cells for Regenerative Medicine Applications